354 related articles for article (PubMed ID: 11428437)
21. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
Sauerbrei A; Wutzler P
J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
[TBL] [Abstract][Full Text] [Related]
22. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
Gershon AA; Steinberg SP
N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
[TBL] [Abstract][Full Text] [Related]
23. Varicella vaccination: evidence for frequent reactivation of the vaccine strain in healthy children.
Krause PR; Klinman DM
Nat Med; 2000 Apr; 6(4):451-4. PubMed ID: 10742154
[TBL] [Abstract][Full Text] [Related]
24. Varicella immunity: persistent serologic non-response to immunization.
Katial RK; Ratto-Kim S; Sitz KV; Moriarity R; Engler RJ
Ann Allergy Asthma Immunol; 1999 May; 82(5):431-4. PubMed ID: 10353572
[TBL] [Abstract][Full Text] [Related]
25. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
[TBL] [Abstract][Full Text] [Related]
26. Immunization of healthy adults with live attenuated varicella vaccine.
Gershon AA; Steinberg SP; LaRussa P; Ferrara A; Hammerschlag M; Gelb L
J Infect Dis; 1988 Jul; 158(1):132-7. PubMed ID: 2839577
[TBL] [Abstract][Full Text] [Related]
27. The optimization and validation of the glycoprotein ELISA assay for quantitative varicella-zoster virus (VZV) antibody detection.
Hammond O; Wang Y; Green T; Antonello J; Kuhn R; Motley C; Stump P; Rich B; Chirmule N; Marchese RD
J Med Virol; 2006 Dec; 78(12):1679-87. PubMed ID: 17063506
[TBL] [Abstract][Full Text] [Related]
28. Seropositivity of Varicella zoster virus in vaccinated Korean children and MAV vaccine group.
Choi UY; Huh DH; Kim JH; Kang JH
Hum Vaccin Immunother; 2016 Oct; 12(10):2560-2564. PubMed ID: 27484734
[TBL] [Abstract][Full Text] [Related]
29. Varicella-zoster virus seroprevalence in healthcare workers in Kuala Lumpur, Malaysia.
Sam IC; Tariman H; Chan YF; Bador MK; Yusof MY; Hassan H
Med J Malaysia; 2008 Dec; 63(5):429-30. PubMed ID: 19803311
[TBL] [Abstract][Full Text] [Related]
30. Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers.
Qureshi M; Gordon SM; Yen-Lieberman B; Litaker DG
Infect Control Hosp Epidemiol; 1999 Jul; 20(7):516-8. PubMed ID: 10432167
[TBL] [Abstract][Full Text] [Related]
31. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
Watson B
J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
[TBL] [Abstract][Full Text] [Related]
32. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
33. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of varicella-zoster virus antibody and immunogenicity of live attenuated varicella vaccine in healthcare workers in Taiwan.
Chong CH; Liu CE; Leong YY; Liao SY; Lai HW; Lee YL
J Microbiol Immunol Infect; 2023 Apr; 56(2):274-281. PubMed ID: 36243667
[TBL] [Abstract][Full Text] [Related]
35. Varicella vaccination in children with steroid-sensitive nephrotic syndrome.
Alpay H; Yildiz N; Onar A; Temizer H; Ozçay S
Pediatr Nephrol; 2002 Mar; 17(3):181-3. PubMed ID: 11956856
[TBL] [Abstract][Full Text] [Related]
36. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
[TBL] [Abstract][Full Text] [Related]
37. Persistence of cell-mediated and humoral immune responses in healthy children immunized with live attenuated varicella vaccine.
Watson B; Gupta R; Randall T; Starr S
J Infect Dis; 1994 Jan; 169(1):197-9. PubMed ID: 8277182
[TBL] [Abstract][Full Text] [Related]
38. A live varicella vaccine in a pediatric community.
Yabuuchi H; Baba K; Tsuda N; Okada S; Nose O; Seino Y; Tomita K; Ha K; Mimaki T; Ogawa M
Biken J; 1984 Sep; 27(2-3):43-9. PubMed ID: 6100057
[TBL] [Abstract][Full Text] [Related]
39. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine.
Terada K; Niizuma T; Ogita S; Kataoka N
Vaccine; 2002 Nov; 20(31-32):3638-43. PubMed ID: 12399190
[TBL] [Abstract][Full Text] [Related]
40. Varicella vaccine: the American experience.
Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
